Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Sun Pharmaceuticals Industries LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524715NSE Symbol: SUNPHARMAP/E(TTM):88.68
ISIN Demat:INE044A01036Div & Yield %:0.76EPS(TTM):17.17
Book Value(Rs):100.2261618Market Cap ( Cr.):365310.75Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 20812.1415585.9814116.0512531.9310303.219006.25
Excise Duty0.000.000.000.000.0023.76
Net Sales20812.1415585.9814116.0512531.9310303.218982.49
Other Income 329.291196.88192.071510.921271.441128.04
Stock Adjustments 237.93183.18179.64-138.60251.30-159.26
Total Income21379.3616966.0414487.7613904.2511825.959951.27
EXPENDITURE :      
Raw Materials 6292.095833.575287.124429.123924.563411.63
Power & Fuel Cost495.21422.33384.16394.74407.28376.17
Employee Cost 2156.952000.781805.981702.771571.341625.00
Other Manufacturing Expenses 1037.321064.32862.12860.05898.51868.18
Selling and Administration Expenses 4326.423514.053309.621919.251503.171467.92
Miscellaneous Expenses 3257.272086.08479.24375.751707.771046.57
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure17565.2614921.1312128.249681.6810012.638795.47
Operating Profit3814.102044.912359.524222.571813.321155.80
Interest 472.18388.10267.52408.01540.92388.31
Gross Profit3341.921656.812092.003814.561272.40767.49
Depreciation1600.871349.951236.43561.56552.95487.24
Profit Before Tax1741.05306.86855.573253.00719.45280.25
Tax752.77-553.58244.91386.461.552.02
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-702.44960.43-231.74-344.60-98.70-27.41
Reported Net Profit1690.72-99.99842.403211.14816.60305.64
Extraordinary Items -1665.671237.51-63.64193.27-1048.68-808.62
Adjusted Net Profit3356.39-1337.50906.043017.871865.281114.26
Adjst. below Net Profit 7.38-14.532675.94-211.5210.1743.10
P & L Balance brought forward13612.0815964.5514005.2712384.6112037.0012486.00
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 2519.302237.951559.061378.96479.16797.74
P & L Balance carried down12790.8813612.0815964.5514005.2712384.6112037.00
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %1150.001000.00750.00400.00275.00200.00
Earnings Per Share-Unit Curr7.05-0.423.5113.383.401.27
Earnings Per Share(Adj)-Unit Curr7.05-0.423.5113.383.401.27
Book Value-Unit Curr98.98102.48112.28101.6895.2193.04